805 related items for PubMed ID: 18269869
1. [Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].
DU ZD, Zhao D, DU JB, Lu S, Yi JM, Hou AC, Zhou ZS, Ding GF, Beijing Kawasaki Disease Epidemilogy Study Grou.
Zhonghua Yi Xue Za Zhi; 2007 Nov 27; 87(44):3119-21. PubMed ID: 18269869
[Abstract] [Full Text] [Related]
2. [Comparison of efficacy among early, conventional and late intravenous gamma globulin treatment of Kawasaki disease].
Du ZD, Di Z, Du JB, Lu S, Yi JM, Hou AC, Zhou ZS, Ding GF.
Zhonghua Yi Xue Za Zhi; 2009 Jul 14; 89(26):1841-3. PubMed ID: 19953930
[Abstract] [Full Text] [Related]
3. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
Khowsathit P, Hong-Hgam C, Khositseth A, Wanitkun S.
J Med Assoc Thai; 2002 Nov 14; 85 Suppl 4():S1121-6. PubMed ID: 12549785
[Abstract] [Full Text] [Related]
4. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
Pediatrics; 2004 Dec 14; 114(6):e689-93. PubMed ID: 15545617
[Abstract] [Full Text] [Related]
5. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Tse SM, Silverman ED, McCrindle BW, Yeung RS.
J Pediatr; 2002 Apr 14; 140(4):450-5. PubMed ID: 12006960
[Abstract] [Full Text] [Related]
6. Intravenous immunoglobulin preparation type: association with outcomes for patients with acute Kawasaki disease.
Manlhiot C, Yeung RS, Chahal N, McCrindle BW.
Pediatr Allergy Immunol; 2010 May 14; 21(3):515-21. PubMed ID: 20546528
[Abstract] [Full Text] [Related]
7. Initial intravenous gamma-globulin treatment failure in Iranian children with Kawasaki disease.
Kashef S, Safari M, Amin R.
Kaohsiung J Med Sci; 2005 Sep 14; 21(9):401-4. PubMed ID: 16248123
[Abstract] [Full Text] [Related]
8. Epidemiologic study of Kawasaki disease at a single hospital in Daejeon, Korea (1987 through 2000).
Lee KY, Han JW, Lee HS, Hong JH, Hahn SH, Lee JS, Whang KT.
Pediatr Infect Dis J; 2004 Jan 14; 23(1):52-5. PubMed ID: 14743047
[Abstract] [Full Text] [Related]
9. Treatment of Kawasaki disease using locally product intravenous immunoglobulin.
Sangtawesin C, Kirawitaya T, Layangkool T, Nawasiri W, Vimolsarawong N.
J Med Assoc Thai; 2003 Aug 14; 86 Suppl 3():S656-60. PubMed ID: 14700163
[Abstract] [Full Text] [Related]
10. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
Uehara R, Belay ED, Maddox RA, Holman RC, Nakamura Y, Yashiro M, Oki I, Ogino H, Schonberger LB, Yanagawa H.
Pediatr Infect Dis J; 2008 Feb 14; 27(2):155-60. PubMed ID: 18174868
[Abstract] [Full Text] [Related]
11. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
Wooditch AC, Aronoff SC.
Pediatrics; 2005 Oct 14; 116(4):989-95. PubMed ID: 16199713
[Abstract] [Full Text] [Related]
12. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
Arch Dis Child; 2008 Feb 14; 93(2):142-6. PubMed ID: 17962370
[Abstract] [Full Text] [Related]
13. Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease.
Sittiwangkul R, Pongprot Y, Silvilairat S, Phornphutkul C.
Singapore Med J; 2006 Sep 14; 47(9):780-4. PubMed ID: 16924360
[Abstract] [Full Text] [Related]
14. Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset.
Fukunishi M, Kikkawa M, Hamana K, Onodera T, Matsuzaki K, Matsumoto Y, Hara J.
J Pediatr; 2000 Aug 14; 137(2):172-6. PubMed ID: 10931407
[Abstract] [Full Text] [Related]
15. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
Wilson N, Heaton P, Calder L, Nicholson R, Stables S, Gavin R.
J Paediatr Child Health; 2004 Aug 14; 40(9-10):524-9. PubMed ID: 15367145
[Abstract] [Full Text] [Related]
16. Immunoglobulin failure and retreatment in Kawasaki disease.
Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C.
Pediatr Cardiol; 2003 Aug 14; 24(2):145-8. PubMed ID: 12457253
[Abstract] [Full Text] [Related]
17. Infections and Kawasaki disease: implications for coronary artery outcome.
Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RS.
Pediatrics; 2005 Dec 14; 116(6):e760-6. PubMed ID: 16322132
[Abstract] [Full Text] [Related]
18. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.
Zhonghua Er Ke Za Zhi; 2006 Dec 14; 44(12):891-5. PubMed ID: 17254453
[Abstract] [Full Text] [Related]
19. Clinical responses of patients with Kawasaki disease to different brands of intravenous immunoglobulin.
Tsai MH, Huang YC, Yen MH, Li CC, Chiu CH, Lin PY, Lin TY, Chang LY.
J Pediatr; 2006 Jan 14; 148(1):38-43. PubMed ID: 16423595
[Abstract] [Full Text] [Related]
20. [Clinical analysis of 942 cases of Kawasaki disease].
Zhang W, Li Q, Zhao XD, Tang XM, Wang XG, Wang M, Wu DQ, Ou Q, Yang XQ.
Zhonghua Er Ke Za Zhi; 2006 May 14; 44(5):324-8. PubMed ID: 16780705
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
